Javascript must be enabled to continue!
5,7- Dimethoxycoumarin Enhances Insulin Release and Stimulates Extrapancreatic Secretion of Amylin.
View through CrossRef
AbstractObjectiveOxidative stress decreases the ability of β-cells to secrete insulin through glucolipotoxicity of the pancreatic islets. Flavonoids modulate insulin and amylin secretion through mainly antioxidant activities. Coumarins isomers of flavonoids have direct effects on the cardiovascular system, not linked to antioxidant activities. This study aimed to investigate the effects of 5,7-dimethoxycoumarin (Citropten) fractions present in grapefruit peel on insulin and amylin secretions in normal male Wistar rats.MethodsMethanol extract of grapefruit peels was fractionated using vacuum assisted liquid chromatography with n-Hexane, Ethyl acetate and Methanol. Gas Chromatography Mass Spectrometry analysis reported ethyl acetate fraction with highest concentration (85.66%) of 5,7-dimethoxycoumarin. Intraperitoneal Glucose Tolerance Test was performed on 5 sets of 5 rats receiving intraperitoneally: 1) negative control, 1ml of sterile water 2) positive control, 0.2mg/kg glimepiride, 3) ethyl acetate fraction containing 10mg/kg, 20mg/kg 5,7-dimethoxycoumarin, 4) methanol fraction containing 10mg/kg, 20mg/kg 5,7-dimethoxycoumarin 5a)1ml H2O2(0.6%, 6%) plus 20mg/kg 5,7-dimethoxycoumarin, and 5b)1000mg/kg Vitamin C plus 20mg/kg 5,7-dimethoxycoumarin.ResultsResults showed ethyl acetate fractions containing 10mg/kg and 20mg/kg 5,7-dimethoxycoumarin had comparable plasma glucose control with glimepiride, with indirect insulin secretion effect unlike direct acting glimepiride; the methanol fraction was less effective. Both ethyl acetate and methanol fractions of 5,7- dimethoxycoumarin induced extrapancreatic amylin synthesis and secretion.Conclusion5,7-dimethoxycoumarin will find special applications in the management of obesity, and diabetics with chronic complications. Since the overall plasma glucose regulation is achieved through amylin and insulin synergy, attention should be shifted from insulin-based to amylin-based therapy. There is need to focus on natural compounds that stimulate extrapancreatic amylin release.
Springer Science and Business Media LLC
Title: 5,7- Dimethoxycoumarin Enhances Insulin Release and Stimulates Extrapancreatic Secretion of Amylin.
Description:
AbstractObjectiveOxidative stress decreases the ability of β-cells to secrete insulin through glucolipotoxicity of the pancreatic islets.
Flavonoids modulate insulin and amylin secretion through mainly antioxidant activities.
Coumarins isomers of flavonoids have direct effects on the cardiovascular system, not linked to antioxidant activities.
This study aimed to investigate the effects of 5,7-dimethoxycoumarin (Citropten) fractions present in grapefruit peel on insulin and amylin secretions in normal male Wistar rats.
MethodsMethanol extract of grapefruit peels was fractionated using vacuum assisted liquid chromatography with n-Hexane, Ethyl acetate and Methanol.
Gas Chromatography Mass Spectrometry analysis reported ethyl acetate fraction with highest concentration (85.
66%) of 5,7-dimethoxycoumarin.
Intraperitoneal Glucose Tolerance Test was performed on 5 sets of 5 rats receiving intraperitoneally: 1) negative control, 1ml of sterile water 2) positive control, 0.
2mg/kg glimepiride, 3) ethyl acetate fraction containing 10mg/kg, 20mg/kg 5,7-dimethoxycoumarin, 4) methanol fraction containing 10mg/kg, 20mg/kg 5,7-dimethoxycoumarin 5a)1ml H2O2(0.
6%, 6%) plus 20mg/kg 5,7-dimethoxycoumarin, and 5b)1000mg/kg Vitamin C plus 20mg/kg 5,7-dimethoxycoumarin.
ResultsResults showed ethyl acetate fractions containing 10mg/kg and 20mg/kg 5,7-dimethoxycoumarin had comparable plasma glucose control with glimepiride, with indirect insulin secretion effect unlike direct acting glimepiride; the methanol fraction was less effective.
Both ethyl acetate and methanol fractions of 5,7- dimethoxycoumarin induced extrapancreatic amylin synthesis and secretion.
Conclusion5,7-dimethoxycoumarin will find special applications in the management of obesity, and diabetics with chronic complications.
Since the overall plasma glucose regulation is achieved through amylin and insulin synergy, attention should be shifted from insulin-based to amylin-based therapy.
There is need to focus on natural compounds that stimulate extrapancreatic amylin release.
Related Results
Developmental Regulation of Amylin and Insulin-Gene Expression in Lean (Fa/Fa) and obese (fa/fa) Zucker rats
Developmental Regulation of Amylin and Insulin-Gene Expression in Lean (Fa/Fa) and obese (fa/fa) Zucker rats
Obese individuals are hyperinsulinemic and insulin resistant. Because amylin is cosecreted with insulin and may contribute to the insulin resistance of obesity, this study tested t...
Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging
Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging
Protein aggregation is associated with various diseases caused by protein misfolding. Among them, amylin deposition is a prominent feature of type 2 diabetes. At present, the mecha...
2064-LB: Novel Amylin and Calcitonin Receptor Coagonists Reduce Food Intake and Body Weight in Rodents
2064-LB: Novel Amylin and Calcitonin Receptor Coagonists Reduce Food Intake and Body Weight in Rodents
Amylin analogs have been shown to significantly reduced body weight and dosage of insulin. Dual amylin and calcitonin receptor agonists (DACRAs) are the most potent amylin receptor...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
Abstract
Abstract 4908
Insulin resistance can be a major problem in patients with diabetes mellitus. Although multiple reasons can result in this prob...
940-P: Porous Insulin Microneedles for Diabetes Treatment
940-P: Porous Insulin Microneedles for Diabetes Treatment
Introduction and Objective: Patients with type 1 and type 2 diabetes are subjected to insulin injection therapies. Repeated subcutaneous insulin administrations leads to physiologi...
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
The aim of this study is to evaluate the cost-effectiveness of continuous subcutaneous insulin infusion (CSII) to multiple daily insulin injection (MDI) either with analogues or w...
WILLINGNESS-TO-PAY FOR INSULIN IN DIABETES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
WILLINGNESS-TO-PAY FOR INSULIN IN DIABETES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
Background: Insulin treatment is necessary for all patients with type 1 diabetes and a subset of patients with type 2 diabetes. However, lifetime insulin treatment is relatively co...

